BNP/CALL/MERCK & CO./105/0.1/17.01.25 Share Price

Warrant

DE000PN7FA51

Market Closed - Deutsche Boerse AG 20:50:23 05/07/2024 BST
2.28 EUR +4.59% Intraday chart for BNP/CALL/MERCK & CO./105/0.1/17.01.25
Current month-2.15%
1 month-10.24%
Date Price Change
05/07/24 2.28 +4.59%
04/07/24 2.18 -1.80%
03/07/24 2.22 -8.64%
02/07/24 2.43 -1.62%
01/07/24 2.47 +6.01%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 08:50 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN7FA5
ISINDE000PN7FA51
Date issued 17/08/2023
Strike 105 $
Maturity 17/01/2025 (194 Days)
Parity 10 : 1
Emission price 1.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.02
Lowest since issue 0.73
Spread 0.01
Spread %0.44%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus